Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.60731 | 25 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.53544 | 23 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.5352 | 23 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.43921 | 21 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.47495 | 22 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.7503 | 30 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.60977 | 25 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.52032 | 23 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.46947 | 21 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.51655 | 23 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.58144 | 26 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.4713 | 21 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.57029 | 25 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.53191 | 23 |